New study reveals novel multi-omics approach with unprecedented treatment response prediction in metastatic urothelial cancer

A pharmacist dispensing medicine to a customer. Apixaban was the highest-costing drug in the NHS – responsible for £430m ($540.8m) spending. Image credit: GettyImages/izusek The

Medical professionals and local leaders discussed their views on the state of healthcare in western North Carolina and what may be done to improve it

Mor­phic Ther­a­peu­tic saw its shares $MORF slide by 25% Fri­day to about $38 af­ter da­ta from a small Phase IIa tri­al showed its in­flam­ma­to­ry bow­el